Microbio Co Ltd (4128) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.010x

Based on the latest financial reports, Microbio Co Ltd (4128) has a cash flow conversion efficiency ratio of -0.010x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-100.20 Million ≈ $-3.16 Million USD) by net assets (NT$10.20 Billion ≈ $321.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 4128 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Microbio Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Microbio Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Microbio Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Microbio Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Ganesha Ecosphere Limited
NSE:GANECOS
0.074x
Te Chang Construction Co Ltd
TWO:5511
0.048x
Chien Kuo Construction Co Ltd
TW:5515
0.378x
Bera Holding AS
IS:BERA
0.013x
PT Estee Gold Feet Tbk
JK:EURO
-0.067x
Bhansali Engineering Polymers Limited
NSE:BEPL
0.036x
Akebia Ther
NASDAQ:AKBA
0.955x
Highlight Tech
TWO:6208
0.085x

Annual Cash Flow Conversion Efficiency for Microbio Co Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Microbio Co Ltd from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see 4128 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$10.20 Billion
≈ $321.50 Million
NT$85.27 Million
≈ $2.69 Million
0.008x -81.28%
2024-12-31 NT$11.87 Billion
≈ $373.94 Million
NT$529.90 Million
≈ $16.69 Million
0.045x +871.28%
2023-12-31 NT$13.50 Billion
≈ $425.34 Million
NT$-78.15 Million
≈ $-2.46 Million
-0.006x -157.28%
2022-12-31 NT$14.01 Billion
≈ $441.34 Million
NT$141.57 Million
≈ $4.46 Million
0.010x +159.17%
2021-12-31 NT$13.84 Billion
≈ $436.15 Million
NT$53.98 Million
≈ $1.70 Million
0.004x -54.37%
2020-12-31 NT$12.85 Billion
≈ $404.91 Million
NT$109.82 Million
≈ $3.46 Million
0.009x +6.78%
2019-12-31 NT$9.04 Billion
≈ $284.89 Million
NT$72.36 Million
≈ $2.28 Million
0.008x +388.65%
2018-12-31 NT$9.68 Billion
≈ $304.91 Million
NT$15.85 Million
≈ $499.33K
0.002x +238.29%
2017-12-31 NT$8.30 Billion
≈ $261.53 Million
NT$-9.83 Million
≈ $-309.70K
-0.001x +94.47%
2016-12-31 NT$8.41 Billion
≈ $265.04 Million
NT$-180.25 Million
≈ $-5.68 Million
-0.021x -18.36%
2015-12-31 NT$8.94 Billion
≈ $281.77 Million
NT$-161.90 Million
≈ $-5.10 Million
-0.018x +1.39%
2014-12-31 NT$9.10 Billion
≈ $286.68 Million
NT$-167.04 Million
≈ $-5.26 Million
-0.018x +9.53%
2013-12-31 NT$8.70 Billion
≈ $274.25 Million
NT$-176.63 Million
≈ $-5.56 Million
-0.020x +3.13%
2012-12-31 NT$6.32 Billion
≈ $199.08 Million
NT$-132.36 Million
≈ $-4.17 Million
-0.021x +51.99%
2011-12-31 NT$6.23 Billion
≈ $196.39 Million
NT$-271.95 Million
≈ $-8.57 Million
-0.044x -142.24%
2010-12-31 NT$5.04 Billion
≈ $158.75 Million
NT$520.41 Million
≈ $16.40 Million
0.103x +211.97%
2009-12-31 NT$5.26 Billion
≈ $165.69 Million
NT$-485.10 Million
≈ $-15.28 Million
-0.092x -15.56%
2008-12-31 NT$1.79 Billion
≈ $56.53 Million
NT$-143.21 Million
≈ $-4.51 Million
-0.080x -8.41%
2007-12-31 NT$1.29 Billion
≈ $40.78 Million
NT$-95.30 Million
≈ $-3.00 Million
-0.074x -1038.56%
2006-12-31 NT$559.40 Million
≈ $17.62 Million
NT$4.39 Million
≈ $138.25K
0.008x --

About Microbio Co Ltd

TWO:4128 Taiwan Packaged Foods
Market Cap
$273.33 Million
NT$8.68 Billion TWD
Market Cap Rank
#15385 Global
#703 in Taiwan
Share Price
NT$14.75
Change (1 day)
+0.34%
52-Week Range
NT$14.30 - NT$26.20
All Time High
NT$158.18
About

Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; pr… Read more